factor IX

Also found in: Medical, Legal, Financial, Encyclopedia, Wikipedia.

factor IX

n.
A protein substance in blood plasma that is essential for the clotting of blood. A deficiency of this factor is the cause of Christmas disease.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.factor IX - coagulation factor whose absence is associated with hemophilia B
Christmas factor
clotting factor, coagulation factor - any of the factors in the blood whose actions are essential for blood coagulation
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in
References in periodicals archive
It is the albumin fusion protein that links recombinant coagulation factor IX with recombinant albumin to treat haemophilia B.
CSL Behring receives US FDA approval for Idelvion
Recently, Cell Genesys published findings in Nature Genetics demonstrating the successful in vivo gene delivery of the factor IX gene utilizing the company's proprietary gene delivery adeno-associated virus vectors to transfer the factor IX gene into targeted cells of the liver in normal mice.
Cell Genesys receives patent for adeno-associated virus gene therapy
Biopharmaceutical company OPKO Health (NYSE:OPK) stated on Friday that it plans to conduct a Phase 2a study of Factor VIIa (Factor VIIa-CTP) for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX.
OPKO submits investigational NDA to begin Phase 2a Trial for Factor VIIa-CTP for treating hemophilia
PCC is utilised for the prophylaxis and treatment of congenital and acquired clotting factor II, factor VII, factor IX or factor X deficiencies, including those caused by haemophilia and other liver diseases.
China Biologic Products receives approval for manufacturing of human prothrombin complex concentrate at Shandong Taibang facility
M2 PHARMA-September 1, 2014-Affinity Biologicals launches Factor VIII, Factor IX Deficient plasma products in Canada, Europe
Affinity Biologicals launches Factor VIII, Factor IX Deficient plasma products in Canada, Europe
United States-based Pfizer has revealed positive results from its Phase III trial comparing a prophylaxis regimen of BeneFIX Coagulation Factor IX (Recombinant) 100 IU/kg once-weekly to on-demand treatment in people with moderately severe to severe hemophilia B, it was reported on Friday.
Pfizer reveals positive results from Phase III trial of BeneFIX
The Fc portion of IgG1 is fused to factor IX in ALPROLIX and is thought to be responsible for the prolonged time ALPROLIX circulates in the body.
Biogen Idec's ALPROLIX PDUFA date extended by the US Food and Drug Administration
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.